Trial Profile
A trial to study the effect of denosumab (Dmab) or Monthly Oral Bisphosphonates (Obps) for the treatment of women with post-menopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 16 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases